Press Releases Surmodics, Inc.

Equities

SRDX

US8688731004

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
32.32 ^USD	+2.31%		-6.45%	-11.09%

02/05	Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating	MT
01/05	Top Midday Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SurModics: Fiscal Q2 Earnings Snapshot	01/05	AQ
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance	01/05	BU
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1	22/04	AQ
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1	19/04	BU
Surmodics to Participate in Upcoming Investor Conferences in March and April	27/02	BU
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results, Updates Fiscal Year 2024 Financial Guidance	02/02	AQ
SurModics: Fiscal Q1 Earnings Snapshot	01/02	AQ
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance	01/02	BU
Surmodics Announces Successful Early Clinical Use of Pounce LP Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli below the Knee	23/01	AQ
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee	22/01	BU
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1	16/01	BU
Surmodics to Host Virtual Annual Meeting of Shareholders	16/01	BU
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium	16/11	BU
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium	16/11	BU
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28	15/11	BU
SurModics: Fiscal Q4 Earnings Snapshot	08/11	AQ
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance	08/11	BU
Surmodics : Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance - Form 8-K	08/11	PU
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium	07/11	BU
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15	07/11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Surmodics, Inc.

Equities

SRDX

US8688731004

Press Releases

Filters